Stay updated on Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.

Latest updates to the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedNew revision entry v3.4.2 appears in the history, replacing the previous v3.4.1. No study data, descriptions, or outcomes are affected by this change.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry v3.4.1 was added to the history and the previous revision v3.4.0 was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now includes a glossary toggle and color-coded change highlights (green for additions, red for deletions). The revision label was updated from v3.3.4 to v3.4.0.SummaryDifference0.8%

- Check61 days agoChange DetectedNew system revision v3.3.4 appears in the history, and the previous revision v3.3.3 is removed from the list.SummaryDifference0.1%

- Check83 days agoChange DetectedA new page revision label (v3.3.3) was added, and the HHS Vulnerability Disclosure link along with the previous revision label (v3.3.2) were removed from the footer.SummaryDifference0.2%

Stay in the know with updates to Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.